No abstract available
MeSH terms
-
Abdomen / pathology
-
Antiviral Agents / adverse effects
-
Antiviral Agents / therapeutic use
-
DNA, Viral / cerebrospinal fluid
-
Enterovirus Infections / blood
-
Enterovirus Infections / cerebrospinal fluid
-
Enterovirus Infections / complications*
-
Enterovirus Infections / drug therapy
-
Hepatitis B, Chronic / drug therapy*
-
Humans
-
Immunocompromised Host / immunology
-
Interferon alpha-2
-
Interferon-alpha / adverse effects
-
Interferon-alpha / therapeutic use*
-
Liver / pathology
-
Lower Extremity / pathology
-
Male
-
Middle Aged
-
Myelitis / blood
-
Myelitis / cerebrospinal fluid
-
Myelitis / drug therapy
-
Myelitis / virology*
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / therapeutic use*
-
Recombinant Proteins
-
Spinal Cord / pathology
-
Treatment Outcome
Substances
-
Antiviral Agents
-
DNA, Viral
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
peginterferon alfa-2a